Attend the FierceBiotech 3rd Drug Development Forum!
The leading executive-level forum for biotech strategy & networking | Oct 1-3 | Boston
UNC scientists are making progress using a personalized form of immunotherapy to eradicate HIV reservoirs.
A newly found stem cell can differentiate into just bone cells without the unwanted lineages found in previous cultures.
An expanded understanding of the genetics behind breast cancer and blood pressure could improve treatments.
An engineered form of a naturally occurring molecule can penetrate hard-to-kill, Gram-negative bacteria.
Targeting a protein called sarcolipin could prompt the body to burn more fat, researchers suggest in a new study.
Swedish scientists have characterized a heterogeneous group of neurons in the inner ear, which could inspire new treatments for hearing loss.
Different KRAS mutations exert diverging effects on protein function, a new study illustrates.
A UCSF spinoff is working with GlaxoSmithKline to develop a drug to target a common mutation in glioblastoma.
Machine learning identified mutations in 60 genes that raise the risk of abdominal aortic aneurysm (AAA).
Swedish researchers have found that the rogue SOD1 protein can “transmit” protein misfolding in ALS.
